34 results
8-K
EX-99.1
ADIL
Adial Pharmaceuticals Inc
14 Nov 23
Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
5:29pm
this acknowledgment validates our progress and innovative approach to treating Alcohol Use Disorder. We remain confident in AD04’s ability to address
8-K
ADIL
Adial Pharmaceuticals Inc
1 Feb 21
Adial Pharmaceuticals Closes Acquisition of Purnovate
5:27pm
structures that include adenosine, an important neurotransmitter. Purnovate uses innovative methods and technologies to enhance the drug properties
8-K
EX-99.1
ADIL
Adial Pharmaceuticals Inc
10 Dec 20
Entry into a Material Definitive Agreement
9:45am
the addiction space as well, including infectious diseases, inflammation, cancer, asthma, and diabetes.”
Purnovate has developed innovative technologies
8-K
ADIL
Adial Pharmaceuticals Inc
10 Dec 20
Entry into a Material Definitive Agreement
9:45am
innovative methods and technologies to enhance the drug properties of purines (“Purines” + “Innovate” = Purnovate). Purnovate, was formed in 2019
424B3
ADIL
Adial Pharmaceuticals Inc
14 Jun 21
Prospectus supplement
5:15pm
that include adenosine, an important neurotransmitter. Purnovate uses innovative methods and technologies to enhance the drug properties of purines (“Purines
POS AM
huuvx2b drxsx33mf
6 Apr 21
Prospectus update (post-effective amendment)
12:00am
POS AM
ogou8wob1syo906p9qg
6 Apr 21
Prospectus update (post-effective amendment)
12:00am
10-K
tqlx1yt2i
19 Feb 19
Annual report
9:30am
424B4
rmmlhh6 4w
22 Feb 19
Prospectus supplement with pricing info
4:06pm